Free Trial

Russell Investments Group Ltd. Buys 81,416 Shares of inTEST Co. $INTT

inTEST logo with Computer and Technology background

Key Points

  • Russell Investments Group Ltd. increased its stake in inTEST Co. by 187% in the first quarter, now owning 1.00% of the company worth $873,000.
  • inTEST Co.'s stock is currently valued at $7.00, showing a 2.5% decline recently, with a market cap of $87.35 million.
  • Analysts have a consensus price target of $12.00 for inTEST, with two analysts rating it a Buy and one holding a Hold rating.
  • MarketBeat previews the top five stocks to own by October 1st.

Russell Investments Group Ltd. increased its holdings in inTEST Co. (NYSE:INTT - Free Report) by 187.0% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 124,959 shares of the company's stock after acquiring an additional 81,416 shares during the quarter. Russell Investments Group Ltd. owned about 1.00% of inTEST worth $873,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in INTT. Northern Trust Corp lifted its stake in inTEST by 8.2% in the fourth quarter. Northern Trust Corp now owns 40,328 shares of the company's stock worth $346,000 after acquiring an additional 3,048 shares during the period. Jane Street Group LLC lifted its stake in inTEST by 9.0% in the fourth quarter. Jane Street Group LLC now owns 31,644 shares of the company's stock worth $272,000 after acquiring an additional 2,602 shares during the period. Ameriprise Financial Inc. lifted its stake in inTEST by 43.2% in the fourth quarter. Ameriprise Financial Inc. now owns 493,524 shares of the company's stock worth $4,239,000 after acquiring an additional 148,784 shares during the period. Farther Finance Advisors LLC purchased a new stake in inTEST in the first quarter worth $41,000. Finally, Byrne Asset Management LLC bought a new stake in shares of inTEST during the first quarter valued at approximately $27,000. Hedge funds and other institutional investors own 63.18% of the company's stock.

inTEST Stock Down 2.1%

Shares of NYSE INTT traded down $0.15 during mid-day trading on Thursday, hitting $7.12. 29,690 shares of the stock traded hands, compared to its average volume of 37,843. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.38 and a current ratio of 2.26. inTEST Co. has a 52 week low of $5.24 and a 52 week high of $9.77. The company has a market cap of $88.84 million, a price-to-earnings ratio of 30.96 and a beta of 1.58. The stock has a fifty day moving average price of $7.20 and a 200-day moving average price of $6.93.

inTEST Company Profile

(Free Report)

inTEST Corporation provides test and process technology solutions for use in manufacturing and testing in automotive, defense/aerospace, industrial, life sciences, security, and semiconductor markets worldwide. The company operates through three segments: Electronic Test, Environmental Technologies, and Process Technologies.

Recommended Stories

Institutional Ownership by Quarter for inTEST (NYSE:INTT)

Should You Invest $1,000 in inTEST Right Now?

Before you consider inTEST, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and inTEST wasn't on the list.

While inTEST currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.